DavidSDunkinMD
Pediatric Gastroenterology • New York, NYPediatric Inflammatory Bowel Disease Gastroenterology
Associate Professor at the Icahn School of Medicine at Mount Sinai
Dr. Dunkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5 E 98th St Fl 10
Mount Sinai Faculty Practice
New York, NY 10029Phone+1 212-241-5415Fax+1 212-831-7974- Is this information wrong?
Summary
- David Dunkin, MD is an Associate Professor of Pediatrics in the Division of Pediatric Gastroenterology. Dr. Dunkin obtained his undergraduate degree from Cornell University and received his MD from the Sackler School of Medicine. He completed his Pediatric residency at Yale Children’s Hospital followed by a fellowship in Pediatric Gastroenterology at the Mount Sinai Medical Center. In addition to his clinical practice, his current research explores the development of food allergies and the use of Chinese herbal medicines for the treatment of IBD. His research has been funded by the National Institutes of Health (NIH). Dr. Dunkin’s clinical practice includes all areas of pediatric gastroenterology with a special interest in inflammatory bowel diseases and immune disorders of the GI tract including eosinophilic esophagitis.
Education & Training
Icahn School of Medicine at Mount Sinai/Kravis Children'sFellowship, Pediatric Gastroenterology, 2006 - 2009
Yale-New Haven Medical CenterResidency, Pediatrics, 2002 - 2005
Tel Aviv University SacklerClass of 2002
Cornell UniversityB.A., Biology and Society, 1992 - 1996
Certifications & Licensure
FL State Medical License 2020 - Present
NY State Medical License 2006 - 2026
CT State Medical License 2005 - 2025
NJ State Medical License 2018 - 2025- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- AGA Fellow (AGAF) American Gastroenterological Association, 2022
- Young Investigator Award NASPGHAN, 2010
- Yale/Johnson-Johnson International Health Scholar 2004
- Join now to see all
Clinical Trials
- Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease Start of enrollment: 2023 Feb 15
- A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) Start of enrollment: 2020 May 18
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease Start of enrollment: 2024 Mar 13
- Join now to see all
Publications & Presentations
PubMed
- Cytomegalovirus Colitis in a Patient with Severe Treatment Refractory Ulcerative Colitis.Michelle M Bao, Juliana M Kennedy, Michael T Dolinger, David Dunkin, Joanne Lai, Marla C Dubinsky> ;Crohn's & Colitis 360. 2024 Jan 1
- 1 citationsSingle-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease.Kellar, A. S., Elizabeth A Spencer, Suzannah Bergstein, Michael Dolinger, Nanci Pittman, Amelia Kellar, David Dunkin, Marla C Dubinsky> ;Inflammatory Bowel Diseases. 2023 Dec 22
- 6 citationsOutcomes of Children with Inflammatory Bowel Disease who Develop Anti-tumour Necrosis Factor-induced Skin Reactions.Michael T Dolinger, Priya Rolfes, Elizabeth Spencer, Guillaume Stoffels, David Dunkin, Marla C Dubinsky> ;Journal of Crohn's & Colitis. 2022 Sep 8
- Join now to see all
Journal Articles
- A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn’s DiseaseDavid Dunkin ∗, Francesco Merlino ∗, Carmen Correale CEACAM5 Working Group Garabet Yeretssian, Luciana Marinelli §, Giulia Roda §, Gastroenterology, 10/2022
- Ganoderic acid C1 isolated from the Anti-asthma Formula, ASHMITM suppresses TNF-alpha production by mouse macrophages and peripheral blood mononuclear cells from asthm...C Liu, N Yang, Y Song, L Wang, J Zi, B Ma, D Dunkin, P Busse, W David, J Tversky, R Miller, J Zhan, XM Li, International Immunopharmacology, 1/1/2015
- Anti-inflammatory Effects of Ganoderma Lucidum Triterpenoid in Human Crohn's Disease Associated with Down-Regulation of NF-kappa B Signaling PathwayDunkin D, Liu C, Lai J, Ceballos C, Benkov K, Li XM, Inflammatory Bowel Diseases, 1/1/2015
- Join now to see all
Press Mentions
DBV Technologies Highlights Research Presentation of EPIT® for the Treatment of Crohn's Disease at Digestive Disease Week 2017May 8th, 2017
Kids with Bedroom Smartphones Sleep Less: StudyJanuary 5th, 2015
Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds - US NewsSeptember 22nd, 2014- Join now to see all
Grant Support
- Career Development AwardCCFA2011–2014
- NIH Career Development Award (K08)NIH NIDDKPresent
Committees
- Member, NASPGHAN IBD Committee 2018 - 2021
- Member, NASPGHAN Research Committee 2012 - 2015
Professional Memberships
- Fellow
- NASPGHANMember
- CCFAMember
Hospital Affiliations
The Mount Sinai HospitalNew York, New York
Mount Sinai Beth IsraelNew York, New York
Mount Sinai MorningsideNew York, New York
Mount Sinai WestNew York, New York
Mount Sinai Hospital of QueensAstoria, New York
External Links
- IBD Centerhttp://www.mountsinai.org/ibd-center
- Mount Sinai Profilehttps://profiles.mountsinai.org/david-dunkin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
